Core Viewpoint - Castle Biosciences, Inc. (CSTL) has seen a 1.5% increase in share price over the past four weeks, closing at 41 indicating a potential upside of 51.5% [1] Price Targets - The average price target consists of nine estimates ranging from a low of 50, with a standard deviation of $5.22, suggesting a potential increase of 18.3% to 84.8% from the current price [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [7] Analyst Sentiment - Analysts have shown increasing optimism about CSTL's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.6%, with no negative revisions [10] Zacks Rank - CSTL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [11] Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to historical inaccuracies in predicting actual stock price movements [5][8]
Wall Street Analysts Think Castle Biosciences (CSTL) Could Surge 51.52%: Read This Before Placing a Bet